NCT02757404View on ClinicalTrials.gov

Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

May 30, 2016

Primary Completion Date

August 16, 2016

Study Completion Date

August 16, 2016

Conditions
Muscle Spasticity
Interventions
DRUG

Ultrasonography guidance injection of Meditoxin®.

Meditoxin® will be injected to upper limb spasticity by using the ultrasonography guidance.

DRUG

Electrical stimulation guidance injection of Meditoxin®.

Meditoxin® will be injected to upper limb spasticity by using the electrical stimulation guidance.

DRUG

Manual needle placement injection of Meditoxin®.

Meditoxin® will be injected to upper limb spasticity by using the manual needle placement.

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT02757404 - Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity | Biotech Hunter | Biotech Hunter